Menu
Dividend AristocratsDividend KingsHigh YieldMonthly DividendDividend CalendarScreener

Kenvue Inc. Stock Price History

Kenvue Inc. EPS

EPSDividend / share
0.00.30.71.01.32022202320242025

Kenvue Inc. Dividend per Share

Forward Yield
4.60%
Annual Dividend
0.83 USD
Payout
98.51%
Frequency
Quarterly
Yrs of growth
2+
CAGR 5Y
0.00.20.40.70.9202320242025

Kenvue Inc. Dividend Yield

Kenvue Inc. Payout Ratio

0%41%81%122%162%202320242025

Kenvue Inc. Dividend Growth

1Y CAGR
3Y CAGR
5Y CAGR
10Y CAGR
20Y CAGR
1.98%
Compound annual growth rate of dividend per share
Yield vs sector
4.60%
avg Consumer Defensive: 4.26%
Next ex-dividend (est.)
2026-08-12
last: 2026-05-13
Ex-DateAmount
2026-05-130.21 USD
2026-02-110.21 USD
2025-11-120.21 USD
2025-08-130.21 USD
2025-05-140.20 USD
2025-02-120.20 USD
2024-11-130.20 USD
2024-08-140.20 USD

Kenvue Inc. is a global consumer health company focused on over-the-counter medicines, personal care, and wellness products for everyday use. Headquartered in Summit, New Jersey, Kenvue develops and markets a broad portfolio of well-known brands across categories such as pain relief, allergy care, cough and cold, digestive health, baby care, skincare, and oral care. Its products include widely recognized names such as Tylenol, Zyrtec, Benadryl, Neutrogena, Aveeno, Listerine, Johnson’s, Band-Aid, and Visine, which are distributed through pharmacies, mass retailers, e-commerce platforms, and healthcare channels worldwide. Kenvue’s business is organized around meeting consumer needs in self-care and daily health routines, offering non-prescription solutions that support hygiene, symptom relief, and skin and hair health. By combining brand recognition, large-scale distribution, and consumer insight-driven product development, Kenvue plays a significant role in the consumer health market, serving households, caregivers, and professionals across multiple regions.